Testing sentinel lymph node surgery for early ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have or may have ovarian cancer that is in an early stage (FIGO I or II), meaning it hasn't spread far.
- You can have surgery to remove the tumor and check nearby lymph nodes.
- You have not had previous surgeries on major blood vessels or lymph nodes in the pelvis or belly.
- You are not allergic to the special dye or tracer used during the procedure.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a technique to find and remove only the lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It uses a special dye to highlight the sentinel lymph nodes, which may reduce side effects while still checking for spread.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial tests a new technique using special dye to help surgeons find and remove the first lymph nodes that drain fluid from ovarian tumors during surgery. This might help doctors better stage your cancer and plan your treatment more accurately.
This trial studies whether taking a sample from the sentinel lymph node during surgery can help with staging early ovarian cancer. It may help doctors find spread to lymph nodes more accurately while limiting unnecessary lymph node removal in some cases.
This trial tests a new way to look at lymph nodes during surgery for gynecologic cancers. It may help doctors decide immediately if cancer has spread to the lymph nodes, which could guide treatment decisions during the same operation.
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.